| Financial Year |
March 31 2023 |
| Monetary Funds |
127,556,170.49 |
| Held-for-trading Financial Assets |
140,463,442.23 |
| Notes Receivable |
187,684,904.23 |
| Accounts Receivable |
224,153,886.72 |
| Advances to Suppliers |
11,378,747.95 |
| Other Receivables |
5,599,715.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
125,197,447.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
28,896,854.51 |
| Total Current Assets |
871,929,740.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
452,054,802.23 |
| Under-construction Projects |
15,985,152.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
50,278,805.29 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
9,676,720.60 |
| Other Non-Current Assets |
3,423,099.34 |
| Sub-Total of Non-Current Assets |
533,757,981.40 |
| Total Assets |
1,405,687,721.72 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
63,035.96 |
| Notes Payable |
98,625,789.28 |
| Accounts Payable |
51,527,372.32 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,583,059.97 |
| Taxes Payable |
10,597,899.13 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,798,062.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
138,340.03 |
| Other Current Liabilities |
112,426,033.83 |
| Sub-Total of Current Liabilities |
301,492,357.52 |
| Long-term Loans |
-- |
| Bonds Payable |
239,921,558.55 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,903,422.02 |
| Other Non-Current Liabilities |
8,260.88 |
| Sub-Total of Non-Current Liabilities |
261,124,375.80 |
| Total Liabilities |
562,616,733.32 |
| Paid-In Capital(Or Share Stock) |
126,881,849.00 |
| Capital Surplus |
242,731,318.33 |
| Surplus Reserve |
40,936,580.16 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
345,288,838.58 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
843,070,988.40 |
| Owner's Equity（Stockholder's Equity） |
843,070,988.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,405,687,721.72 |
